|Bid||0.00 x 200|
|Ask||1,490.00 x 5000|
|Day's Range||1,426.00 - 1,449.00|
|52 Week Range||1,290.00 - 1,835.00|
|PE Ratio (TTM)||288.65|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
For the first nine months of fiscal 2017, Walgreens Boots Alliance’s adjusted diluted net earnings per share increased 7.7% YoY to $3.79.
The massive online retailer with a reputation for disruption could be coming for the notoriously complex, opaque drug industry.
Anthem’s entry is notable in a highly concentrated industry dominated by just a few large players.
Anthem plans to launch its own pharmacy-benefit manager, serviced by CVS Health, in 2020 after the conclusion of its contract with Express Scripts.
Anthem will launch its own pharmacy benefit management business, relying heavily on CVS Health for both back-end processing and retail distribution.
Health insurer Anthem Inc will start managing its billions of dollars of patient prescriptions itself in 2020, it said on Wednesday, ending a deal with Express Scripts Holding Co that had deteriorated into lawsuits over terms. Anthem said it would save $4 billion annually in the new contract with drug retailer CVS Health Corp, which will handle prescription fulfillment and claims processing starting in 2020 for five years for the new company, called IngenioRX. The new structure gives Anthem more control to lower healthcare costs, expand contracting with doctors and hospitals based on health outcomes and work on lowering annual increases in medical costs, Anthem Chief Executive Joseph Swedish said in an interview.
The contentious pricing battle between Anthem (ANTM) and Express Scripts (ESRX) has come to an end, and it isn’t with reconciliation. Early today, Anthem, one of the nation’s largest providers of Blue Cross health plans, announced it would launch its own pharmacy benefit manager, IngenioRx, in 2020 to provide services to Anthem health plans, as well as outside customers. In a separate announcement, Anthem said it has inked a five-year deal with CVS Health (CVS) to process claims for IngenioRx and fill prescriptions.
Anthem will launch its own new pharmacy benefit management company called IngenioRx in partnership with CVS Health, effective in January of 2020.
CVS will take over services for Anthem's pharmacy benefits manager IngenioRx when Anthem's deal with Express Scripts runs out in 2020.
Anthem Inc. plans to launch its own pharmacy-benefits manager, IngenioRx, which will provide services to Anthem health plans and non-Anthem customers starting in 2020, which is when Anthem's contract with ...
Drug retailer CVS Health Corp said on Wednesday it entered into an agreement with Anthem Inc to provide services to the health insurer's newly launched pharmacy benefit management business, IngenioRx. ...
Of the 25 analysts tracking WBA in October 2017, ~68% recommended a “buy” rating on the stock while the rest suggested a “hold.”
On October 6, CNBC reported that Amazon plans to sell prescription drugs online. Walgreens stock fell 7.7%, while CVS stock fell 5.6% last week.
Walgreens’ US Retail Pharmacy business, which generates more than 70% of the company’s total sales, has enjoyed decent sales growth. Its top line improved 3.1% in the first nine months of fiscal 2016.
CVS generates close to 70% of its annual sales by offering a full range of pharmacy benefit management services.
The US drugstore market is dominated by two major players—CVS Health (CVS) and Walgreens Boots Alliance (WBA). CVS and WBA accounted for ~29% of the country's prescription dispensing revenues in 2016.
On October 11, CVS Health touched its 11-month low and traded at $73.90. The company has lost 6.3% year-to-date.